Home ContractsProvision of HTLV Pathology Services

Provision of HTLV Pathology Services

WAC ID:665379

NHS & HealthcareAward noticeClosed32014L0024

Source:	Find a Tender Service (FTS)
Notice Type:	Award notice
Buyer:	Imperial College Healthcare NHS Trust
Main Category:	Services
Procurement Method:	Award procedure without prior publication of a call for competition
Method Rationale:	The Molecular Diagnostic Unit (MDU) at Imperial College London <br/>is the only capable provider. <br/>The MDU provides NCHR with bespoke diagnostic assays that <br/>have been developed and validated for NCHR by the Section of <br/>Virology for patient benefit. These assays are essential for the <br/>assessment of HTLV-1-associated disease risk and are used to <br/>determine the frequency of clinic visits, (optimizing the use of <br/>clinical services), detect and allow early treatment of HTLV-1<br/>associated disease and monitor treatment responses. <br/>Continued provision of these assays by the MDU is justified on <br/>the following grounds: <br/>• The assays were developed by the MDU as part of the <br/>HTLV National Service provision. <br/>• The assays are either only available in the UK at the <br/>MDU (HTLV proviral quantification) or are only available <br/>in the World at the MDU (HTLV Clonality Assay). <br/>• The assays would not have been developed without the <br/>partnership between ICHNT/ICL. <br/>• Samples sent for proviral load quantification are stored <br/>viably to allow access to cells for the HTLV clonality <br/>Assay later (once the proviral load is known). <br/>• The MDU is uniquely placed to provide interpretation and <br/>clinical support. <br/>• All patients in England receive the same standard of care, which <br/>is world leading. The Direct Award Process A justification is <br/>based on the provider’s specialist HTLV assay capability, <br/>validated methodology, continuity of stored viable samples, <br/>UKAS-accredited laboratory provision, and clinical integration <br/>with the National Centre for Human Retrovirology. (Supporting <br/>evidence available and retained to demonstrate that there is no <br/>realistic alternative provider for the full requirement)

🤝 Need a consortium or subcontracting partner?

SMEs & Primes team up to win opportunities like this. Find partners on the board.

Find partners →

Award outcome

Awarded to

Molecular Diagnostic Unit, Imperial College LondonGB-FTS-187546

Award status:

Active

Contracting Authority

Organisation

Imperial College Healthcare NHS Trust

St Mary's Hospital, Praed Street, London, W2 1NY

Description

The HTLV pathology service will support the diagnosis, prognosis and monitoring of: • HTLV infection with the provision of assays to detect, type and quantify HTLV infection, and • HTLV associated diseases particularly detection of high risk for or early disease and the monitoring of interventions to inform disease management.

CPV Classifications1 code — click to expand

85111800Health and social work services

Pipeline status

Not added

Add to pipeline

Imports the contract into your BidWriter pipeline · Qualify before you commit to bid

Assign to team member

Delegate this bid in BidWriter

Run Bid / No Bid analysis

Score this opportunity in BidWriter

WAC Reference

WAC-665379